NCT05657665

Brief Summary

The primary objective is to gather missing information in order to form a well-founded recommendation on which is the preferred skin pigmentation measurement (PPM) methods in the context of pulse-oximetry.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 20, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

February 6, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 11, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 11, 2023

Completed
Last Updated

April 12, 2023

Status Verified

April 1, 2023

Enrollment Period

2 months

First QC Date

December 12, 2022

Last Update Submit

April 11, 2023

Conditions

Keywords

Skin typesPulse oximetry

Outcome Measures

Primary Outcomes (1)

  • Preferred skin PMM in the context of pulse-oximetry.

    The primary objective is to complement a previous skin pigmentation study executed by Philips to gather missing information in order to form a well-founded recommendation on which is the preferred skin PPM in the context of pulse-oximetry.

    10 months

Interventions

Objective and subjective skin tone measurements will be performed.

Eligibility Criteria

Age18 Years - 66 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Healthy volunteers with Von Luschan scores \<18 ('light skin' group) or \> 25 ('dark skin' group.

You may qualify if:

  • Adults (18-65 years)
  • Fluent in either English or Dutch
  • Participants who are willing and able to provide informed consent themselves.
  • People with Von Luschan scores \<18 ('light skin' group) or \> 25 ('dark skin' group).

You may not qualify if:

  • Skin conditions that could potentially interfere with the measurements:
  • piercings/ink/henna tattoos that cover the left forearm, hands, fingers or forehead
  • vascular or pigmentary or renal psoriasis
  • epidermal bullosum
  • other diseases that affect the skin (tone) of the body
  • Currently displaying COVID-19-related symptoms, namely a fever, cough and/or difficulty breathing
  • Having been positively tested as infected with COVID-19 in the past 14 days
  • Travelled to or from high risk COVID-19 areas in the past 14 days
  • Been in contact with a (suspected) COVID-infected person in the past 14 days
  • Not being able to travel to Eindhoven 3 times, and/or not being able to comply with the study procedures
  • Sunbathing during the study duration or substantial sun exposure (due to holidays for example).
  • Known allergic reaction to facial make-up
  • Usage of tanning sprays/cremes
  • Wearing make-up during the study visits (mascara is allowed)
  • No testing will be performed in the study. Participants will be asked if they have been positively tested.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

High Tech Campus

Eindhoven, Netherlands

Location

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2022

First Posted

December 20, 2022

Study Start

February 6, 2023

Primary Completion

April 11, 2023

Study Completion

April 11, 2023

Last Updated

April 12, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

The plan is to perform data analysis by Philips Research. Thereafter data will be shared (de-identified) in a seperate publication that can be accessed overall.

Locations